EVT-201 ATC code show
7-Chloro-3-{5-[(dimethylamino)methyl]-1,2,4-oxadiazol-3-yl}-5-methyl-4,5-dihydro-6H -imidazo[1,5-a ][1,4]benzodiazepin-6-one
CAS Number PubChem CID ChemSpider UNII Formula C 17 H 17 Cl N 6 O 2 Molar mass 372.81 g·mol−1 3D model (JSmol ) show
Clc4cccc3n2cnc(c1nc(on1)CN(C)C)c2CN(C(=O)c34)C
show
InChI=1S/C17H17ClN6O2/c1-22(2)8-13-20-16(21-26-13)15-12-7-23(3)17(25)14-10(18)5-4-6-11(14)24(12)9-19-15/h4-6,9H,7-8H2,1-3H3
Key:JCYLWUVDHLVGER-UHFFFAOYSA-N
EVT-201 is a benzodiazepine derivative drug and partial positive allosteric modulator of the benzodiazepine site of the GABAA receptor .[1] It has 2–4-fold higher functional affinity for the α1 subunit relative to the α2 , α3 , and α5 subunits and significantly less intrinsic activity in comparison to currently-marketed benzodiazepines and the Z-drugs .[2] Despite the lower efficacy, EVT-201 still shows effectiveness in the treatment of insomnia , and it is thought that the lower efficacy may result in fewer side effects , such as motor incoordination .[2] The drug was originally developed by Roche , based on preclinical data, as a non-sedating anxiolytic , but was found to produce sedation in humans in phase I clinical trials . For this reason, it was subsequently licensed to Evotec, which is now developing it for the treatment of insomnia.[2] As of 2007 , EVT-201 has completed phase II clinical trials for this indication, with positive findings reported.[3] As of August 2015 , Phase II development is ongoing in China .[4]
See also [ ]
References [ ]
External links [ ]
show Insomnia pharmacotherapies
GABAA R PAMs
Benzodiazepines : Brotizolam
Cinolazepam
Climazolam
Clorazepate
Doxefazepam
Estazolam
Etizolam
Flunitrazepam
Flurazepam
Flutoprazepam
Haloxazolam
Loprazolam
Lormetazepam
Midazolam
Nimetazepam
Nitrazepam
Quazepam
Temazepam
Triazolam ; Nonbenzodiazepines /Z-drugs : Eszopiclone
Zaleplon
Zolpidem
Zopiclone ; Others: Alcohols (e.g., ethchlorvynol , amylene hydrate , ethanol )
Barbiturates (e.g., amobarbital , pentobarbital , phenobarbital , secobarbital )
Bromides (e.g., potassium bromide , sodium bromide )
Carbamates (e.g., meprobamate )
Chloral hydrate
Clomethiazole
Kava
Paraldehyde
Piperidinediones (e.g., glutethimide )
Quinazolinones (e.g., methaqualone )
Sulfonmethane
Valerian
Antihistamines (H1 R inverse agonists ) OXR antagonists MTR agonists Miscellaneous
Antipsychotics (e.g., quetiapine , olanzapine , chlorpromazine )
Ashwagandha
Benzoctamine
Cannabinoids (e.g., cannabis , dronabinol (THC ) , nabilone )
Chamomile
Fenadiazole
Gabapentinoids (e.g., gabapentin , pregabalin , phenibut )
Hops
Lavender
Menthyl isovalerate
Niaprazine
Opioids (e.g., hydrocodone , oxycodone , morphine )
Passion flower
Scopolamine
Serotonin precursors (tryptophan , 5-HTP )
Sodium oxybate (GHB )
Sympatholytics (e.g., clonidine , guanfacine )
TCAs (e.g., amitriptyline , doxepin , trimipramine )
TeCAs (e.g., mirtazapine )
Theanine
Trazodone
Valnoctamide
show GABA A receptor positive modulatorsAlcohols
Butanol
Chloralodol
Chlorobutanol (cloretone)
Ethanol (alcohol) (alcoholic drink )
Ethchlorvynol
Isobutanol
Isopropanol
Menthol
Methanol
Methylpentynol
Pentanol
Petrichloral
Propanol
tert -Butanol (2M2P)
tert -Pentanol (2M2B)
Tribromoethanol
Trichloroethanol
Triclofos
Trifluoroethanol
Barbiturates Benzodiazepines Carbamates Flavonoids
Ampelopsin (dihydromyricetin)
Apigenin
Baicalein
Baicalin
Catechin
EGC
EGCG
Hispidulin
Luteolin
Skullcap constituents (e.g., baicalin )
Wogonin
Imidazoles Kava constituents
Desmethoxyyangonin
Kavain
Methysticin
Yangonin
Monoureides Neuroactive steroids Nonbenzodiazepines Phenols
Fospropofol
Propofol
Thymol
Piperidinediones Pyrazolopyridines Quinazolinones Volatiles /gases
Acetone
Acetophenone
Acetylglycinamide chloral hydrate
Aliflurane
Benzene
Butane
Butylene
Centalun
Chloral
Chloral betaine
Chloral hydrate
Chloroform
Cryofluorane
Desflurane
Dichloralphenazone
Dichloromethane
Diethyl ether
Enflurane
Ethyl chloride
Ethylene
Fluroxene
Gasoline
Halopropane
Halothane
Isoflurane
Kerosine
Methoxyflurane
Methoxypropane
Nitric oxide
Nitrogen
Nitrous oxide
Norflurane
Paraldehyde
Propane
Propylene
Roflurane
Sevoflurane
Synthane
Teflurane
Toluene
Trichloroethane (methyl chloroform)
Trichloroethylene
Vinyl ether
Others/unsorted
3-Hydroxybutanal
Avermectins (e.g., ivermectin )
Bromide compounds (e.g., lithium bromide , potassium bromide , sodium bromide )
Carbamazepine
Chloralose
Chlormezanone
Clomethiazole
DEABL
Dihydroergolines (e.g., dihydroergocryptine , , dihydroergotamine , ergoloid (dihydroergotoxine) )
Efavirenz
Etazepine
Etifoxine
Fenamates (e.g., flufenamic acid , mefenamic acid , niflumic acid , tolfenamic acid )
Fluoxetine
Flupirtine
Hopantenic acid
Lanthanum
Lavender oil
Lignans (e.g., 4-O-methylhonokiol , honokiol , magnolol , obovatol )
Loreclezole
Menthyl isovalerate (validolum)
Monastrol
Niacin
Niacinamide
Org 25,435
Phenytoin
Propanidid
Retigabine (ezogabine)
Safranal
Seproxetine
Stiripentol
(e.g., sulfonmethane (sulfonal) , tetronal , trional )
Terpenoids (e.g., borneol )
Topiramate
Valerian constituents (e.g., isovaleric acid , isovaleramide , valerenic acid , )
Unsorted benzodiazepine site positive modulators: α-Pinene
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators
show Benzodiazepines
1,4-Benzodiazepines 1,5-Benzodiazepines 2,3-Benzodiazepines* Triazolobenzodiazepines
Adinazolam
Alprazolam
Balovaptan *
Bromazolam
Clonazolam
Estazolam
Flualprazolam
Flubromazolam
Flunitrazolam
Nitrazolam
Phenazolam
Pyrazolam
Rilmazolam (active metabolite of Rilmazafone )
Triazolam
Imidazobenzodiazepines
Bretazenil
Climazolam
EVT-201
FG-8205
Flumazenil
GL-II-73
Imidazenil
123 I-Iomazenil
L-655,708
Loprazolam
Midazolam
PWZ-029
Remimazolam
Ro15-4513
Ro48-6791
Ro48-8684
Ro4938581
Sarmazenil
SH-053-R-CH3-2′F
Oxazolobenzodiazepines Thienodiazepines Thienotriazolodiazepines Thienobenzodiazepines *Pyridodiazepines Pyridotriazolodiazepines Pyrazolodiazepines Pyrrolodiazepines Tetrahydroisoquinobenzodiazepines Pyrrolobenzodiazepines *Benzodiazepine prodrugs * atypical activity profile (not GABAA receptor ligands)